SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

TOI

The Oncology Institute Inc.
NASDAQHealth Care

Latest close: 6.43 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 2, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 21, 2026Reported sale · Form 4Brad Hively · $1.9MOpen the filing ↗
  3. Aug 21, 2026Notice of sale · Form 144BRADFORD HIVELY · Director · $2.0MOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year244
SEC filings on record52215 flagged findings
Reported transactions (Form 4)71since Mar 17, 2023 · and 10 other holdings
Corporate events (8-K)30since Aug 10, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-18share offering or dilution eventrecentOpen filing ↗
    “…CFR 240.14d-2(b)) ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities…”
  • 2026-05-22share offering or dilution eventrecentOpen filing ↗
    “…CFR 240.14d-2(b)) ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities…”
  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…CFR 240.14d-2(b)) ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities…”
  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…of 7,446,562 shares of common stock (collectively, the “PIPE”). In connection with the PIPE, certain Lenders under the Company’s…”
    +1 more passage from the same document
    • “…with the PIPE, certain Lenders under the Company’s Facility Agreement exercised their Participation Rights and entered into an…”
  • 2026-05-07merger or acquisition eventrecentOpen filing ↗
    “…or terminated a Rule 10b-5 trading arrangement or a non-Rule 10b-5 trading arrangement during the three months ended March 31,…”
  • 2026-03-13share offering or dilution eventrecentOpen filing ↗
    “…CFR 240.14d-2(b)) ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 522)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 2, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 24, 26Form 4 ↗Insider transaction
  • Aug 21, 26Form 144 ↗Notice of proposed sale
  • Aug 21, 268-K ↗Current report · Entered a material agreement
  • Aug 17, 26Form 4 ↗Insider transaction
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results
  • Aug 3, 268-K ↗Current report · Bylaws or fiscal year change · Communication to the market
  • Insider transaction · 9 Form 4 filingsshow all 9hide
  • Jul 14, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Jul 7, 268-K ↗Current report · Entered a material agreement
  • Jun 24, 26Form 4 ↗Insider transaction
  • Jun 18, 268-K ↗Current report · Shareholder vote results
  • Jun 9, 26Form 4 ↗Insider transaction

522 filings on record, the oldest from Feb 21, 20.

Listing the 25 most recent filings of the 522 on record.

8-Ks, explained

Stress6Structure22Governance22
  • Sep 2, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 21, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 7, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • May 22, 26StressCybersecurity incident (8-K 1.05)+1 more in the same filing8-K 1.05 ↗
  • Governance5 senior executive changes2025 – 2026show all 5hide
    • Feb 23, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jan 7, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 1, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Aug 13, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 7, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 27, 25StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Mar 25, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Feb 26, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Dec 19, 24StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Nov 12, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 23, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 21, 24StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗

9 older filings not shown · The record reaches back to Mar 13, 20.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Apr 27, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Dec 9, 21StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • May 18, 21StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • M33 Growth I L.P.4.9%May 14, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Ravi Sarin4.7%Mar 26, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 21, BRADFORD HIVELY filed notice of intent to sell up to $2.0M. That is about 0.29% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $1.9M on Aug 21, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+1 more recent notices · 1 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 21, 26Sell$1.9MBrad Hively↗
  • Aug 14, 26Buy$78KJorey Chernett↗
  • Jul 21, 26Buy$95KJorey Chernett↗
  • Jul 14, 26Sell$116KYale PodnosChief Medical Officer↗
  • Jul 14, 26Sell$35KYale PodnosChief Medical Officer↗
  • Jul 10, 26Buy$88KJorey Chernett↗
  • Jun 23, 26Buy$90KJorey Chernett↗
  • Jun 8, 26Sell$126KYale PodnosChief Medical Officer↗
  • Jun 4, 26Buy$57KJorey Chernett↗
  • May 20, 26Buy$136KJorey Chernett↗
  • May 19, 26Buy$123KJorey Chernett↗
  • May 19, 26Buy$20KJorey Chernett↗

There are 6 more transactions in this stretch.

Stock compensation, tax and giftsshow the 22 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jul 27, 26Compensationamount n/aKaren Marie Johnson↗
  • Jul 27, 26Compensationamount n/aBrad Hively↗
  • Jul 27, 26Compensationamount n/aKIMBERLY JO TZOUMAKAS↗
  • Jul 27, 26Compensationamount n/aMARK STOLPER↗
  • Jul 27, 26Compensationamount n/aMark L Pacala↗
  • Jul 27, 26Compensationamount n/aAnne McGeorge↗
  • Jul 27, 26Compensationamount n/aMohit Kaushal↗
  • Jul 14, 26Compensation$34KYale PodnosChief Medical Officer↗
  • Jul 14, 26Compensation$11KYale PodnosChief Medical Officer↗
  • Jul 7, 26Compensationamount n/aMARK STOLPER↗
  • Jul 7, 26Compensationamount n/aKIMBERLY JO TZOUMAKAS↗
  • May 21, 26Other$7KRobert Ross CarterChief Financial Officer↗
  • May 21, 26Other$103KDaniel VirnichChief Executive Officer↗
  • May 21, 26Other$8KYale PodnosChief Medical Officer↗
  • Mar 27, 26Compensationamount n/aDaniel VirnichChief Executive Officer↗
  • Mar 27, 26Other$302KDaniel VirnichChief Executive Officer↗
  • Mar 27, 26Compensationamount n/aRobert Ross CarterChief Financial Officer↗
  • Mar 27, 26Other$62KRobert Ross CarterChief Financial Officer↗
  • Mar 27, 26Compensationamount n/aYale PodnosChief Medical Officer↗
  • Mar 27, 26Other$50KYale PodnosChief Medical Officer↗
  • Mar 27, 26Compensationamount n/aKristin EnglandChief Administrative Officer↗
  • Mar 27, 26Compensationamount n/aJeffrey LangsamChief Clinical Officer↗

The full record holds 200 transactions and goes back to Mar 17, 23.

Its sector and its market

The Oncology Institute Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From The Oncology Institute Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow The Oncology Institute Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
244 clean closes in the period.
SEC records
522 documents on file, from Feb 21, 2020 to Sep 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.